FilmArray® Torch delivers high throughput, radically smaller footprint
Asia
Europe, Middle East, Africa
North America
bioMérieux acquires Applied Maths and enhances its bioinformatics capabilities with cutting-edge expertise and solutions for the smart use of complex biological data
05 January, 2016
bioMérieux, a world leader in the field of in vitro diagnostics, today announced the acquisition of Applied Maths, a company that develops state-of-the-art software solutions for the biosciences, in particular for databasing, analysis and interpretation of complex biological data.
bioMérieux and Illumina announce the launch of bioMérieux EpiSeq™, a revolutionary Next-Generation Sequencing service for epidemiological monitoring of bacterial infections
15 December, 2015
bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina (Nasdaq: ILMN), a world leader in genomics, announce the launch of bioMérieux EpiSeq™, an innovative next-generation sequencing (NGS) service dedicated to the epidemiological monitoring and control of healthcare-associated infections.
bioMérieux is a proud supporter of Get Smart about Antibiotics Week
19 November, 2015
World leader in microbiology launches educational campaign focused on antibiotic resistance
bioMérieux introduces GENE-UP®, a new molecular diagnostic solution for food pathogen detection jointly developed with BioFire
04 November, 2015
New generation PCR system benefits from the combined expertise of bioMérieux, world leader in microbiological food safety control and of BioFire, reputed for its know-how in molecular biology
bioMérieux – Business review for the nine months ended September 30, 2015
22 October, 2015
MARCY L'ETOILE – October 22, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2015.
In an extremely favorable business momentum BioFire Diagnostics receives a de novo clearance by the FDA for the FilmArray® Meningitis/Encephalitis panel
12 October, 2015
FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platform
Second National Forum on Sepsis Coverage on U.S. News & World Report
18 September, 2015
From U.S. News & World Report: Sepsis is responsible for 250,000 deaths a year in the U.S., mostly because treatment isn't given in time.
bioMérieux Joins the Rory Staunton Foundation at the Second National Forum on Sepsis: “Let’s Save Lives”
16 September, 2015
Event to be held in Washington D.C. and will feature Sen. Charles E. Schumer (D-NY) and Families from around the nation who have been impacted by sepsis.